However, HNSCC exhibits a high degree of tumor heterogeneity, which can lead to inaccurate determination of PD-L1 during biopsy, thereby reducing the predictive efficacy of ICIs treatment (39). The gene discussed is CD274; the disease is head and neck squamous cell carcinoma.